title: Denosumab and atypical femoral fractures.
authors.forename: Per
authors.initials: P
authors.lastname: Aspenberg
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069448:Denosumab; D005264:Femoral Fractures / Q000139:chemically induced*; D015775:Fractures, Stress / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy; D058866:Osteoporotic Fractures / Q000517:prevention & control
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D050071:Bone Density Conservation Agents; D000069448:Denosumab